CClinicalTrials.gg
Sign In
Status unknownNCT00410137Updated Dec 12, 2006

Influence of Nutritional and Inflammational Status on Survival of Hemodialysis Patients

An observational study in Inflammation and Body Composition, sponsored by Assaf-Harofeh Medical Center. Status unknown at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2006-12-12.

Sponsored by Assaf-Harofeh Medical Center · Observational

The sponsor has not verified this record recently (last verified Dec 2006), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Defined population
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

prospective longitudinal measurements of nutritional status parameters (body composition by BIA, anthropometry and biochemical indexes), inflammatory response (CRP, inflammatory cytokines (IL-1, IL-6, IL-10),IGF-1, leptin and NOx blood levels) and morbidity and mortality data collection over 2 year period in patients receiving chronic hemodialysis.

02

Conditions studied

  • Inflammation
  • Body Composition

Browse trials for

03

In context

Inflammation

3,439 studies on the registry are indexed under Inflammation; 629 are open to participants now.

This study's enrollment of 100 is close to the median of 95 across 895 observational studies indexed under Inflammation.

Browse Inflammation studies →

Lead sponsor

Assaf-Harofeh Medical Center is the lead sponsor of 258 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Male or female, age > 18 years, in chronic hemodialysis treatment at least 3 months
  • Stable and adequate hemodialysis treatment three months prior to participation in study as defined by Kt/V > 1.2 and/or hemodialysis performed 4 hours 3 times weekly
  • Patients with normal hydration status (edema-free), with no neuro-muscular diseases
  • Informed consent obtained before any trial-related activities

Exclusion criteria

Exclusion Criteria:

  • Patients with edema, pleural effusion or ascites at their initial assessment
  • Patients with active malignant disease or liver cirrhosis
  • Patients with neuro-muscular diseases
  • Patients on chronic treatment with steroids on doses > 10 mg/day Prednisone (or equivalent)
  • Patients treated with immunosuppressive agents

  • Patients suffering from

    • Acute vasculitis
    • Severe systemic infections
    • Heart failure (NYHA class III-IV)
  • The receipt of any investigational drug within 1 month prior to initiating of this study
05

Study design

Observational model
Defined population
Time perspective
Prospective
Enrollment
100 participants
06

Study locations

1 of 1 sites recruiting
  • Assaf-Harofeh Medical Center
    Zerifin, 70300, Israel
    • Ilia Beberashvili, MD · Contact · iliab@asaf.health.gov.il · +972577346133
    • Ilia Beberashvili, MD · Principal investigator
    Recruiting
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 12, 2006, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00410137
Lead sponsor
Assaf-Harofeh Medical Center
First posted
Dec 12, 2006
Start date
Mar 2006
Completion
Apr 2008
Last update
Dec 12, 2006

Study contacts

Ilia Beberashvili, MD
principal investigator · Assaf-Harofeh Medical Center
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2006. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Inflammation→

Other studies from this sponsor

Assaf-Harofeh Medical Center

Start the discussion